Boazak EM, Greene Jr VK, Auguste DT. The effect of heterobifunctional crosslinkers on HEMA hydrogel modulus and toughness. PloS one. 2019 May 9;14(5):e0215895.
Kim B, Pena CD, Auguste DT. Targeted lipid nanoemulsions encapsulating epigenetic drugs exhibit selective cytotoxicity on CDH1-/FOXM1+ triple negative breast cancer cells. Molecular pharmaceutics. 2019 Mar 18.
Guo P, Yang J, Liu D, Huang L, Fell G, Huang J, Moses MA, Auguste DT. Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis. Science advances. 2019 Mar 1;5(3):eaav5010.
Large DE, Soucy JR, Hebert, J, Auguste DT. Advances in receptor-mediated, tumor-targeted drug delivery. Advanced Therapeutics. 2018 Sept; 1-27.
Liu D, Auguste DT. Peptide density targets and impedes triple negative breast cancer metastasis. Nature Communications. 2018 Jul; 9:2612.
Guo P, Wang B, Liu D, Yang J, Subramanyam K, McCarthy C, Hebert J, Moses M, Auguste DT. Using atomic force microscopy to predict tumor specificity of ICAM1 antibody-directed nanomedicines. Nano Letters. 2018 April; 18:2254-2262
Guo P, Liu D, Subramanyam K, Wang B, Yang J, Huang J, Auguste DT, Moses MA. Nanoparticle elasticity directs tumor uptake. Nature Communications. 2018 Jan; 9:130
Mansfield L, Greene V, Auguste DT. Patterned, tubular scaffolds mimic longitudinal and radial mechanics of the neonatal trachea. Acta Biomaterialia. Accepted.
Guo P, Yang J, Jia D, Moses MA, Auguste DT. ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer, Theranostics. 2016 Jan 1;6(1):1-13.
Guo P, Huang J, Wang L, Jia D, Yang J, Dillon DA, et al. ICAM-1 as a molecular target for triple negative breast cancer. Proc Natl Acad Sci [Internet]. 2014 Sep 29 [cited 2014 Oct 1]; Available from: http://www.pnas.org/cgi/doi/10.1073/pnas.1408556111
Guo P, You J-O, Yang J, Jia D, Moses MA, Auguste DT. Inhibiting Metastatic Breast Cancer Cell Migration via the Synergy of Targeted, pH-triggered siRNA Delivery and Chemokine Axis Blockade. Mol Pharm. 2014 Mar 3;11(3):755–65.
You J-O, Guo P, Auguste DT. A drug-delivery vehicle combining the targeting and thermal ablation of HER2+ breast-cancer cells with triggered drug release. Angew Chem Int Ed Engl. 2013 Apr 8;52(15):4141–6.
Gunawan R, Almeda D, Auguste DT, “Complementary targeting of liposome to IL-1α and TNF-α activated endothelial cells via the transient expression of VCAM1 and E-selectin,” Biomaterials 2011, 32: 9848-9858. (pdf)
You J, Rafat M, and Auguste DT. Crosslinked, heterogeneous colloidosomes exhibit pH-induced morphogenesis. Langmuir 2011; 27(18): 11282-11286; published online, DOI: 10.1021/la202430m. (pdf)
You J, Rafat M, Ye GJC, Auguste DT, “Nanoengineering the heart: Conductive scaffolds enhance connexin 43 expression,” Nano Letters; 2011 Sep 14; 11(9): 3643-8; published online, DOI: 10.1021/nl201514a. (pdf)
You J, Almeda D, Ye GJC, Auguste DT. Bioresponsive matrices in drug delivery. Journal of Biological Engineering 2010; 4:15. (pdf)
Gunawan R, Auguste DT. Immunoliposomes that target endothelium in vitro are dependent on lipid raft formation. Molecular Pharmaceutics 2010; 7(5):1569-1575. (pdf)